Ress Life Investments A/S
Ress Life Investments A/S publishes portfolio composition for Q2 2025
Ress Life Investments A/S publishes portfolio composition for Q2 2025
Ress Life Investments A/S
Nybrogade 12
DK-1203 Copenhagen
Denmark
CVR nr. 33593163
resslifeinvestments.com
To: Nasdaq Copenhagen
Date: 7 August 2025
Corporate Announcement 25/2025
Ress Life Investments A/S publishes portfolio composition for Q2 2025
Ress Life Investments A/S hereby publishes a portfolio overview for the benefit of the company’s shareholders.
Questions related to this announcement can be made to the company’s AIF-manager, Resscapital AB.
Contact person:
Gustaf Hagerud
gustaf.hagerud@resscapital.com
Tel + 46 8 545 282 09
Note: The terms for subscription of shares, minimum subscription amount and redemption of shares are provided in the Articles of Association, Information Brochure and in the PRIIPS KIID documentation available on the Company's website, www.resslifeinvestments.com.
As per 30 June 2025, the number of life insurance policies in Ress Life Investments’ (“RLI”) portfolio is 375. The total face value of the portfolio exceeds USD 1.1 billion.
During Q2 2025 RLI entered into an agreement whereby most of its life insurance portfolio as per end of 2024 (“Legacy Portfolio”) was sold to a market counterparty. The transaction is completed in separate quarterly tranches until the end of Q3 2026. Furthermore, RLI will maintain a portion of future portfolio performance in the Legacy Portfolio above a threshold, even past the end of Q3 2026.
The below portfolio composition is based on a combination of new policies and policies that are part of the Legacy Portfolio. As of 30 June 2025, RLI maintained a 62.5% ownership of the Legacy Portfolio.
Portfolio composition as of 2025-06-30
Top 10 Carriers | Weight % of portfolio value |
John Hancock Life Insurance Company USA | 16.5% |
Lincoln National Life Insurance Company | 15.3% |
AXA Equitable Life Insurance Company | 6.0% |
American General Life Insurance Company | 5.0% |
Pruco Life Insurance Company Inc | 4.5% |
Brighthouse Life Insurance Company | 4.0% |
Pacific Life Insurance Company | 3.7% |
Protective Life Insurance Company | 3.3% |
Transamerica Life Insurance Company | 3.2% |
Principal Life Insurance Company | 3.0% |
Carrier Rating | Weight % of face value |
A++ | 6.8% |
A+ | 46.4% |
A | 42.2% |
A- | 0.1% |
B++ | 3.9% |
B+ | 0.0% |
B | 0.0% |
B- | 0.2% |
C++ | 0.5% |
Top 10 States | Weight % of face value |
FLORIDA | 15.8% |
CALIFORNIA | 12.3% |
NEW YORK | 7.5% |
PENNSYLVANIA | 6.9% |
TEXAS | 6.3% |
MASSACHUSETTS | 4.8% |
OHIO | 4.4% |
NEW JERSEY | 4.2% |
MISSOURI | 3.9% |
ARIZONA | 3.6% |
Face Group | Weight % of face value |
100,000-250,000 | 0.2% |
250,001-500,000 | 1.5% |
500,001-1,000,000 | 8.3% |
1,000,001-2,000,000 | 13.4% |
2,000,001-3,000,000 | 10.8% |
3,000,001-5,000,000 | 22.3% |
5,000,001-10,000,000 | 29.0% |
10,000,001-15,000,000 | 7.3% |
15,000,001- | 7.2% |
Age Group | Weight % of face value |
< 65 | 5.0% |
65 – 69 | 14.1% |
70 – 74 | 20.2% |
75 – 79 | 22.4% |
80 – 84 | 15.7% |
85 – 89 | 11.9% |
90 – 94 | 7.7% |
95 < | 3.1% |
Gender | Weight % of face value |
Female | 13.8% |
Male | 63.1% |
Joint | 23.0% |
DISCLAIMER This information does not constitute or form part of either an invitation, offer or recommendation. Neither Resscapital nor any of their respective directors, officers, employees or any other person makes any promise as to the fairness, accuracy or completeness of this information, or of any other information or opinions, whether written or oral, that have been prepared or furnished by Resscapital. Without prejudice to the foregoing, neither Resscapital, nor any of their respective directors, officers, employees or advisers nor any other person shall be liable for any loss or damage (whether direct, indirect or consequential) suffered by any person as a result of relying on any statement in or omission from this information. The information should not be construed as legal, financial, accounting, tax or other advice.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Boehringer Ingelheim Limited8.8.2025 21:25:53 CEST | Press release
U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
European Investment Bank8.8.2025 18:07:24 CEST | Press release
EIB submits SEC Form 18-K/A Amendment No. 4 - Unaudited Condensed Semi-Annual Financial Statements as at and for the six-month period ended June 30, 2025
European Investment Bank8.8.2025 18:04:10 CEST | Press release
EIB submits Form 18-K/A Amendment No.3 - December 2024 EIB Group Risk Management Disclosure Report
SBM Offshore Amsterdam B.V.8.8.2025 18:01:27 CEST | Press release
FPSO ONE GUYANA producing and on hire
Vaisala Group8.8.2025 17:30:00 CEST | Press release
Vaisala Corporation: Share Repurchase 8.8.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom